Spyridon Gerou

563 total citations
31 papers, 393 citations indexed

About

Spyridon Gerou is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Spyridon Gerou has authored 31 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Oncology. Recurrent topics in Spyridon Gerou's work include Bone health and treatments (4 papers), Bone health and osteoporosis research (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Spyridon Gerou is often cited by papers focused on Bone health and treatments (4 papers), Bone health and osteoporosis research (4 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). Spyridon Gerou collaborates with scholars based in Greece, Netherlands and United Arab Emirates. Spyridon Gerou's co-authors include Athanasios D. Anastasilakis, Polyzois Makras, Athina Gkiomisi, G Sakellariou, Socrates E. Papapoulos, Stergios A. Pοlyzos, Anargyros Kourtis, Maria P. Yavropoulou, Fotini Papadopoulou and Kali Makedou and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Bone.

In The Last Decade

Spyridon Gerou

26 papers receiving 372 citations

Peers

Spyridon Gerou
Spyridon Gerou
Citations per year, relative to Spyridon Gerou Spyridon Gerou (= 1×) peers Svetlana Trofimov

Countries citing papers authored by Spyridon Gerou

Since Specialization
Citations

This map shows the geographic impact of Spyridon Gerou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Spyridon Gerou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Spyridon Gerou more than expected).

Fields of papers citing papers by Spyridon Gerou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Spyridon Gerou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Spyridon Gerou. The network helps show where Spyridon Gerou may publish in the future.

Co-authorship network of co-authors of Spyridon Gerou

This figure shows the co-authorship network connecting the top 25 collaborators of Spyridon Gerou. A scholar is included among the top collaborators of Spyridon Gerou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Spyridon Gerou. Spyridon Gerou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lazaros, Konstantinos, Marios Papasotiriou, Stavroula Siamoglou, et al.. (2025). Impact of CYP3A4 and ABCB1 genetic variants on tacrolimus dosing in Greek kidney transplant recipients. Frontiers in Pharmacology. 16. 1538432–1538432.
2.
Makri, Evangelia, Konstantinos Xanthopoulos, Antonis Goulas, et al.. (2025). Limited preventive effects of empagliflozin against metabolic dysfunction-associated steatotic liver disease in a mouse model of fast food diet. Endocrine Abstracts.
3.
Makri, Evangelia, Konstantinos Xanthopoulos, Antonis Goulas, et al.. (2024). Limited preventive effects of empagliflozin against metabolic dysfunction-associated steatotic liver disease in a mouse model of fast food diet. HORMONES. 24(2). 419–431.
4.
Makri, Evangelia, Konstantinos Xanthopoulos, Anastasia Tsingotjidou, et al.. (2024). Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease. Endocrine. 85(2). 704–716. 2 indexed citations
5.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Panagiotis A. Vorkas, et al.. (2023). Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study. Journal of Clinical Medicine. 12(16). 5430–5430. 1 indexed citations
6.
Anastasilakis, Athanasios D., Polyzois Makras, Athina Gkiomisi, et al.. (2022). The effect of pharmacological cessation and restoration of menstrual cycle on bone metabolism in premenopausal women with endometriosis. Bone. 158. 116354–116354. 2 indexed citations
7.
Bakirtzis, Christos, Ioannis Nikolaidis, Konstantinos Natsis, et al.. (2022). Shrimp sign in a case of progressive multifocal leukoencephalopathy under fingolimod treatment. 2. 100105–100105.
8.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Dimitrios Kitridis, et al.. (2021). Ιrisin levels in postmenopausal women with an incident hip fracture. Endocrine. 73(3). 719–722. 4 indexed citations
9.
Kotsa, Kalliopi, Theocharis Koufakis, Iakovos Avramidis, et al.. (2020). Fasting insulin levels correlate with the frequency of hypoglycemic events in people with type 2 diabetes on treatment with sulfonylureas: A pilot study. Indian Journal of Pharmacology. 52(1). 44–44.
10.
Karras, Spyridon Ν., Theocharis Koufakis, Maria P. Yavropoulou, et al.. (2019). Rising Glucagon-Like Peptide 1 Concentrations After Parathyroidectomy in Patients With Primary Hyperparathyroidism. Journal of Surgical Research. 245. 22–30. 9 indexed citations
11.
Anagnostis, Panagiotis, et al.. (2018). Pretibial myxedema in a euthyroid patient. HORMONES. 17(1). 133–135. 6 indexed citations
12.
Anastasilakis, Athanasios D., Maria P. Yavropoulou, Polyzois Makras, et al.. (2017). Increased osteoclastogenesis in patients with vertebral fractures following discontinuation of denosumab treatment. European Journal of Endocrinology. 176(6). 677–683. 74 indexed citations
13.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Athina Gkiomisi, et al.. (2013). Comparative Effect of Zoledronic Acid Versus Denosumab on Serum Sclerostin and Dickkopf-1 Levels of Naive Postmenopausal Women With Low Bone Mass: A Randomized, Head-to-Head Clinical Trial. The Journal of Clinical Endocrinology & Metabolism. 98(8). 3206–3212. 40 indexed citations
14.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, Polyzois Makras, et al.. (2012). Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass. Bone. 50(5). 1130–1134. 29 indexed citations
15.
Gkiomisi, Athina, Kali Makedou, Athanasios D. Anastasilakis, et al.. (2012). Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum. Cytokine. 61(1). 127–132. 23 indexed citations
16.
Anastasilakis, Athanasios D., Stergios A. Pοlyzos, S. Delaroudis, et al.. (2012). The role of cytokines and adipocytokines in zoledronate‐induced acute phase reaction in postmenopausal women with low bone mass. Clinical Endocrinology. 77(6). 816–822. 6 indexed citations
17.
Kourtis, Anargyros, Athina Gkiomisi, Kali Makedou, et al.. (2011). Apelin levels in normal pregnancy. Clinical Endocrinology. 75(3). 367–371. 38 indexed citations
18.
Makedou, Kali, Anargyros Kourtis, Athina Gkiomisi, et al.. (2011). Oxidized low-density lipoprotein and adiponectin levels in pregnancy. Gynecological Endocrinology. 27(12). 1070–1073. 16 indexed citations
19.
Anastasilakis, Athanasios D., et al.. (2010). A case report of subacute thyroiditis during pregnancy: difficulties in differential diagnosis and changes in cytokine levels. Gynecological Endocrinology. 27(6). 384–390. 7 indexed citations
20.
Goulis, Dimitrios G., Paschalia K. Iliadou, Christos Tsametis, et al.. (2008). Serum anti-Müllerian hormone levels differentiate control from subfertile men but not men with different causes of subfertility. Gynecological Endocrinology. 24(3). 158–160. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026